Meta(META.US)據報考慮放棄開源AI模型 轉向開發封閉模型
《紐約時報》報道,Meta(META.US)新成立超級智能實驗室(Superintelligence Lab)高層討論從開源人工智能(AI)模型Behemoth轉向開發封閉模型的計劃。報道引述消息指,Meta已完成對Behemoth的訓練,但內部測試表現不符預期,因而推遲發佈。報道又指,當新的超級智能實驗室啓動時,對該模型的測試經已停止。
資訊科技媒體《TechCrunch》報道引述Meta發言人指,Meta對開源AI的立場沒有改變,但未對公司可能放棄Behemoth的轉向發表評論。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.